2017 edition

​The 2017 edition of the Rhinology Future Debates was held on 8 December 2017, in Brussels, Belgium.  The following sessions were discussed between Industry representatives, patients representatives and expert panelists.

  • ​Debate I
    Real World Evidence data in AIT - what does it bring to us?
    Panellists:   Jean Bousquet, Claus Bachert, Peter Hellings, Oliver Pfaar, David Price, Glenis Scadding, & Emmanuel Prokopakis
  • Debate II
    Positioning Dymista in allergic rhinitis treatment
    Panellists: David Price, Glenis Scadding, Claus Bachert, Peter Hellings, Wytske Fokkens, Emmanuel Prokopakis, Oliver Pfaar, Jean Bousquet, & Patient representative
  • Debate III
    Nasal turbinate as therapeutic target
    Panellists:   Glenis Scadding, Claus Bachert, Peter Hellings, Wytske Fokkens, Emmanuel Prokopakis, & Patient representatives
  • Debate IV
    Lessons from biologicals in asthma for ENT
    Panellists: Peter Hellings, Claus Bachert, Guy Joos, Renaud Louis. Charles Pilette, David Price, Glenis Scadding, Wytske Fokkens, & Patient representatives

    Read the 2017 report

Impressions of the 2017 edition

Visit our facebook page for more impressions

Debate II 2017

Debate III 2017

Debate IV 2017

They dare going to uncharted waters in the discussion, and I think this is a really good learning experience for everybody

Anders Weilandt - Chordate Medical

Partners of the 2017 Rhinology Future Debates

Stallergenes Greer, Mylan, Chordate, Medtronic, Sanofi & AstraZeneca

​Special thanks to BMW Brussels for their logistical support

More info

If you would like to propose a topic, learn about the partnership opportunities, the programme of the next editions, or any other enquiries regarding the Respiratory Future Debates, please contact us.